Lexaria Bioscience (LEXX) Financials

$12.48

$-0.73 (-5.53%)

As on 03-Sep-2026 13:13EDT

Market cap

$17 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
Operating Revenue	0.19	0.71	0.46	0.23	0.26	0.72
Cost of Revenue	0.07	0.00	0.00	0.03	0.07	0.18
Gross Profit	0.17	0.70	0.46	0.19	0.18	0.55
Operating Expenses	7.90	12.58	6.21	6.73	6.80	6.23
Operating Profit (EBIT)	-7.71	-11.88	-5.75	-6.53	-6.62	-5.69
Other Income	--	--	--	--	--	--
Profit before Tax	-7.74	-11.91	-5.81	-6.71	-7.38	-4.16
Provision for Tax	0.00	--	--	0.13	-0.11	-1.66
Profit after Tax (Net Income)	-7.73	-11.90	-5.80	-6.66	-7.27	-4.03
Minority Interest	0.01	0.01	0.01	0.05	0.11	0.16
Consolidated Profit	--	--	--	--	-7.27	-4.03

Liabilities ($ Mln)	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
Shareholder's Funds	4.74	2.99	8.04	3.04	7.95	13.27
Minority Interest	0.01	--	--	--	--	--
Non-Current Liabilities	0.05	0.08	0.11	0.14	0.01	0.05
Current Liabilities	0.38	1.49	1.10	0.27	0.19	0.15
Total Liabilities	5.16	4.18	8.87	3.08	7.83	13.27

Assets ($ Mln)	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
Non-Current Assets	0.72	0.71	0.97	0.88	0.86	0.82
Current Assets	4.06	3.47	7.90	2.20	6.98	12.44
Total Assets	5.16	4.18	8.87	3.08	7.83	13.27
Total Debt*	0.09	0.11	0.14	0.16	0.05	0.10
Net Current Assets	3.68	1.97	6.80	1.93	6.78	12.29

Cashflow ($ Mln)	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
Cash From Operating Activities	--	-10.45	-4.96	-5.88	-4.88	-3.99
Cash Flow from Investing Activities	--	-0.24	-0.19	-0.17	-0.18	0.19
Cash from Financing Activities	--	6.05	10.32	1.59	-0.04	13.42
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
ROCE (%)	--	-211.16	-101.83	-118.94	-68.06	-50.20
ROE (%)	-160.06	-215.88	-104.60	-121.26	-68.53	-51.00
ROA (%)	-115.45	-182.50	-96.98	-122.09	-68.90	-50.04
EBIT Margin (%)	-2,960.35	-1,687.36	-1,251.12	-2,967.41	-2,891.05	-576.16
Net Margin (%)	-3,985.58	-1,686.00	-1,248.25	-2,946.36	-2,846.28	-557.19
Cash Profit Margin (%)	-0.05	--	--	--	--	--

Growth Ratios	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
Revenue Growth (%)	-68.50	0.52	1.05	-0.11	-0.65	0.88
EBIT Growth (%)	49.63	-105.06	13.47	9.09	-77.31	-0.37
Net Profit Growth (%)	32.13	-105.37	13.05	8.31	-80.51	-2.36
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	4.07	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-7.22	0.16	1.12	0.20	0.84	2.90
Close Price ($)	9.03	13.20	58.65	15.75	44.40	93.30
High Price ($)	23.25	65.70	102.75	53.93	108.00	187.50
Low Price ($)	6.90	11.62	12.66	9.73	27.75	59.63
Market Cap ($ Cr)	17.10	--	--	--	--	--

Solvency Ratios	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
Debt to Equity	--	0.04	0.02	0.05	0.01	0.01
Short term debt to equity ratio	0.01	0.01	0.00	0.01	0.01	0.00
Current Ratio	10.60	2.32	7.18	8.22	35.96	81.18
Quick Ratio	10.60	--	--	8.22	35.76	80.99
Interest Coverage	--	--	--	--	-64.58	--

Operating Efficiency Ratios	TTM	Aug-25	Aug-24	Aug-23	Aug-22	Aug-21	Aug-20	Aug-19	Aug-18	Aug-17	Aug-16
Debtors to sales (%)	25.26	24.65	33.27	77.47	79.01	47.38
Asset Turnover	0.03	0.11	0.08	0.04	0.02	0.09
Receivable days	--	84.98	129.70	304.39	389.13	165.84
Inventory Days	--	--	0.08	222.74	173.03	152.60
Payable days	--	162,678.93	48,588.36	2,001.25	572.06	156.20
Cash Conversion Cycle	--	--	-48,458.59	-1,474.12	-9.90	162.25

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.